4 completed, 3 recruiting, 2 withdrawn, 1 not yet recruiting. 11 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 11 | Completed 4, Recruiting 3, Withdrawn 2, Not yet recruiting 1, Unknown 1 |
Follow Suppuration: new trials by email Literature Review of Suppuration trials Research Report on Suppuration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chloramphenicol, Tetracycline, Zinc Oxide and Eugenol Paste (CTZ Paste) for Emergency Dental Treatment in Public Health Settings: A Randomized Trial CTZ Paste, ZOE Pulpectomy - Pulp Disease, Dental, Pulp Necrosis | Early Phase 1 | Not yet recruiting | University of Sao Paulo | 110 | 2026-06-08 | 2026-05-12 |
| Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa. Siplizumab - Hidradenitis Suppurativa | Early Phase 1 | Recruiting | University of Alabama at Birmingham | 12 | 2025-05-09 | 2026-09-01 |
| Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1% EVO101 - Hidradenitis Suppurativa (HS) | Early Phase 1 | Recruiting | Virginia Clinical Research, Inc. | 15 | 2024-12-03 | 2024-12-11 |
| Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa Fecal Microbiota - lyophilized, Placebo drug - Hidradenitis Suppurativa | Early Phase 1 | Recruiting | University of Minnesota | 16 | 2023-12-27 | 2026-09-03 |
| Fractional CO2 Laser Fenestration and Steroid Delivery in HS Lesions Triamcinolone Topical, Fractional Ablative CO2 Therapy, EMLA 5% cream - Scar, Hidradenitis Suppurativa | Early Phase 1 | Unknown | University of Southern California | 10 | 2022-11-01 | 2022-10-14 |
| Efficacy and Safety of Infliximab Biosimilar in the Treatment of Resistant Hidradenitis Suppurativa Infliximab-dyyb biosimilar - Hidradenitis Suppurativa | Early Phase 1 | Completed | Services Institute of Medical Sciences, Pakistan | 37 | 2022-10-01 | 2023-11-29 |
| Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa Brodalumab - Hidradenitis Suppurativa, Acne Inversa | Early Phase 1 | Completed | Rockefeller University | 4 | 2021-08-05 | 2022-07-27 |
| Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab. Guselkumab - Hidradenitis Suppurativa | Early Phase 1 | Withdrawn | Rockefeller University | 2020-06-01 | 2020-06-05 | |
| An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab Brodalumab - Hidradenitis Suppurativa | Early Phase 1 | Withdrawn | Rockefeller University | 2020-02-03 | 2020-09-04 | |
| Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab Brodalumab - Hidradenitis Suppurativa | Early Phase 1 | Completed | Rockefeller University | 10 | 2019-05-28 | 2020-06-04 |
| Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa secukinumab - Hidradenitis Suppurativa | Early Phase 1 | Completed | Tufts Medical Center | 20 | 2016-07-11 | 2019-06-03 |
Hidradenitis Suppurativa (10) · Cicatrix (1) · Dental Pulp Diseases (1) · Dental Pulp Necrosis (1) · Fistula (1) · Periapical Abscess (1)
Infections (11) · Bacterial Infections (10) · Bacterial Infections and Mycoses (10) · Hidradenitis (10) · Skin Diseases (10) · Skin Diseases, Bacterial (10) · Skin Diseases, Infectious (10) · Skin and Connective Tissue Diseases (10) · Sweat Gland Diseases (10) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Abscess (1) · Fibrosis (1) · Jaw Diseases (1)
brodalumab (3) · CT-P13 (1) · Lidocaine, Prilocaine Drug Combination (1) · guselkumab (1) · secukinumab (1) · siplizumab (1)
Rockefeller University (4) · Services Institute of Medical Sciences, Pakistan (1) · Tufts Medical Center (1) · University of Alabama at Birmingham (1) · University of Minnesota (1) · University of Sao Paulo (1) · University of Southern California (1) · Virginia Clinical Research, Inc. (1)
United States (8) · Pakistan (1)
John W Frew, MD (3) · David Rosmarin, MD (1) · Hira Tariq, FCPS Derma (1) · Noah Goldfarb, MD (1) · Sarah McClees, MD (1) · Yael Renert-Yuval, MD (1)
PMID 12140476, PMID 14632813, PMID 17587838, PMID 19036028, PMID 19293006, PMID 19438670, PMID 20039918, PMID 20166154, PMID 22236226, PMID 23460557, PMID 23904820, PMID 25396122, PMID 26119625, PMID 26470622, PMID 27692735, PMID 30087573, PMID 30872156, PMID 30886476, PMID 31604104, PMID 31688123, PMID 32460374, PMID 33002270, PMID 33548397, PMID 33890304, PMID 35160122, PMID 35333217